Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Dr. Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Dr. Jim Jinn-Chyuan Sheu is a professor at the Institute of Biomedical Sciences, National Sun Yat-sen University, Taiwan, and an adjunct professor in several prestigious institutions. With a PhD in Life Science from National Tsing-Hua University, his academic and industrial experiences span cancer genetics, precision medicine, and biopharmaceuticals. He has held positions at Johns Hopkins Medical Institutions and Development Center for Biotechnology. His research explores molecular mechanisms underlying diseases such as cancer and endometriosis, employing genome-wide technologies to identify biomarkers and drug targets. He actively contributes to biomedical innovation, translational medicine, and mentorship. Dr. Sheu has received numerous national and international awards, including the Wu-Da-You Memorial Award and Sigma Xi membership. He is also an ambassador for the European Association for Cancer Research. As a prolific researcher and reviewer, he plays key roles in research councils and institutional review boards, helping shape scientific policy and translational biomedical advancements in Taiwan and beyond.

Profile

Education šŸŽ“

Dr. Sheu earned his Ph.D. in Life Science from National Tsing-Hua University, Taiwan, in 2002, where he focused on advanced molecular biology, gene expression regulation, and biomedical research. His doctoral training provided a strong foundation in cancer genetics and systems biology. Earlier, he completed his B.S. in Biology (now Life Science) from Fu-Jen University in 1994, building core competencies in biological sciences and cellular mechanisms. These educational milestones equipped him with theoretical knowledge and technical skills in genomics, proteomics, and cellular signaling, which are now reflected in his research on chromatin remodeling, cancer biomarkers, and therapeutic targets. Through rigorous academic mentorship, Dr. Sheu gained early exposure to multidisciplinary research and critical analysis, fostering his interest in precision medicine. His academic background laid the groundwork for his contributions to biomedical research, drug development, and translational science. These formative years in Taiwan’s top universities underpin his long-standing excellence in scientific discovery and innovation.

Experience šŸ‘Øā€šŸ«

Dr. Sheu’s professional experience includes faculty roles and research leadership across academia and industry. He has served as a Professor at National Sun Yat-sen University since 2014 and previously held faculty roles at China Medical University. Internationally, he was a Research Fellow at Johns Hopkins Medical Institutions (2004–2006). Between 2003–2004, he worked in various leadership positions at the Development Center for Biotechnology, including Director of Protein Drugs Division and Project Leader. His postdoctoral and early research roles included work with Dr. Tse-Wen Chang and Dr. Carmay Lim at Academia Sinica. His academic leadership includes roles such as Associate VP of R&D, Chair of the Institute of Biomedical Sciences, and Director of Research Resources at NSYSU. He has reviewed research proposals for numerous hospitals and institutions, served on IRBs, and guided government research policy. His diverse experience bridges basic science, translational research, and biomedical entrepreneurship with national and global impact.

Awards & Recognitions šŸ…

Dr. Sheu has received over 30 prestigious awards. In 2023 alone, he earned the Tien-Te Lee Award, NSYSU Outstanding Faculty Award, and top honors at the 37th Joint Biomedical Conference. He previously received the Prof. Chii-Ruey Tzeng Award, Sigma Xi membership (2021), and EACR Ambassador role (2020). His innovation was recognized by Future Tech Award and the 2020 Smart Life Innovation Competition. His studies were featured as Taiwan Research Highlights and F1000Prime recommendations. He was the 2014 recipient of the Wu-Da-You Memorial Award and the IBC Outstanding Scientific Achievement Award. He received the Medical Young Investigator Award in 2009 and the Best Basic Science Award at Johns Hopkins in 2005. As a government-financed scholar to the U.S., his academic excellence has been internationally recognized. He consistently ranks among Taiwan’s top biomedical researchers, illustrating his impact through award-winning research in endometriosis, cancer stemness, diagnostics, and therapeutic innovation.

Research Interests šŸ”¬

Dr. Sheu’s research focuses on cancer genetics and genomics, endometriosis, precision medicine, chromatin remodeling, cytoskeletal dynamics, cell adhesion and invasion, and mechanotransduction. His lab investigates how abnormalities in gene expression and chromatin structure drive disease progression, especially in gynecologic cancers and endometriosis. By applying genome-wide analysis and bioinformatics, his team identifies disease-driving genes and develops novel diagnostic tools and therapeutic strategies. A key interest is the tumor microenvironment and how cytoskeletal networks and nuclear architecture influence cancer stemness and metastasis. His group explores traditional Chinese medicine compounds and stem cell therapies, advancing integrative approaches to medicine. Antibody and vaccine engineering are also integral to his translational pipeline. Funded by NSTC Taiwan and other institutions, his projects target non-invasive diagnostics and biomarker-based interventions. His long-term vision involves bridging molecular biology, clinical application, and therapeutic innovation to impact patient care and global health through interdisciplinary and precision-driven biomedical science.

Publications

PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. šŸ§¬šŸ”¬

Profile

Education šŸŽ“

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. šŸŽ“šŸ“š

Experience šŸ‘Øā€šŸ«

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. šŸ”¬šŸ’”

Research Interests šŸ”¬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. šŸ”¬šŸ§¬

Awards & Recognitions šŸ…

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. šŸ†šŸ…

Publications šŸ“š

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 |Ā Journal article
    CONTRIBUTORS:Ā PhongSon Dinh;Ā ChauMyThanh Tran;Ā ThiPhuongHoai Dinh;Ā Hai-Anh Ha;Ā Aigul Utegenova;Ā Awais Ali;Ā Abdulaziz Alamri
  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 |Ā Journal article
    CONTRIBUTORS:Ā PhongSon Dinh;Ā ChauMyThanh Tran;Ā ThiPhuongHoai Dinh;Ā Awais Ali;Ā ShangLing Pan
  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 |Ā Journal article
    CONTRIBUTORS:Ā ChauMyThanh Tran;Ā PhongSon Dinh
  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 |Ā Journal article
    Part ofĀ ISSN:Ā 2297-055X
    CONTRIBUTORS:Ā PhongSon Dinh;Ā JunHua Peng;Ā ThanhLoan Tran;Ā DongFeng Wu;Ā ChauMyThanh Tran;Ā ThiPhuongHoai Dinh;Ā ShangLing Pan

Lekshmi K. Edison | Molecular Biology | Best Researcher Award

Dr.Lekshmi K. Edison | Molecular Biology| Best Researcher Award

 

University of Florida, United States

Profile

Education

She earned her Ph.D. in Biotechnology from the University of Kerala, India, in 2019. Prior to that, she completed a Master’s in Biotechnology from Mahatma Gandhi University in 2006 and an undergraduate degree in Zoology from the same university in 2004. Additionally, she holds a Master’s Diploma in Bioinformatics from Bharathiyar University (2015) and a Diploma in Computer Application from C-Dit, India (2014).

Work experience

She is currently a Postdoctoral Associate at the College of Veterinary Medicine, University of Florida, Gainesville, FL, United States, a position she has held since 2022. Prior to this, she worked as a Postdoctoral Associate at the College of Medicine, University of Florida, from 2021 to 2022. From 2019 to 2021, she served as a Postdoctoral Research Associate at the Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, Kerala, India. Earlier in her career, she was a Research Fellow at KSCSTE-JNTBGRI, Palode, Kerala, from 2015 to 2019, and a Project Fellow at the Department of Plant Physiology, College of Agriculture, Vellayani, Kerala, from 2011 to 2013.

Awards

She has received several prestigious honors and awards throughout her career. In 2024, she was awarded the UF Postdoctoral Affairs Spring 2024 Travel Award by the University of Florida and the American Society of Microbiology (ASM) Future Leaders Mentorship Fellowship (FLMF). In 2023, she received the American Society of Virology Postdoctoral Scholar Travel Award. Earlier, she was honored with the Department of Biotechnology-Research Associateship Program Fellowship from the Government of India in 2019. Additionally, she received the Women Scientist’s Back to Lab Research Fellowship from the State Government of Kerala, India, in 2015, and qualified for the National Eligibility Test for Lectureship conducted by the Indian Council of Agricultural Research, Government of India, in 2014.

Ā OTHER PROFESSIONAL CREDENTIALS (LICENSURE, CERTIFICATION, ETC)

She has obtained multiple professional certifications and training credentials. In 2024, she completed the HiPerGator Account Training at the University of Florida, along with certifications in NIH Recombinant DNA (rDNA) and Nanoparticle Biosafety/Biosecurity through CITI. She also received training from the American Association for Laboratory Animal Science (AALAS) in areas such as working safely with rabbits and ferrets in biocontainment and working with laboratory rats. In 2023, she completed the Life Sciences Responsible Conduct of Research Course, training on COVID-19 vaccine research, and multiple AALAS certifications, including working with the IACUC and poultry in laboratories. Earlier, in 2021, she acquired certifications in laboratory animal science, pain management in research animals, and post-procedure care for mice and rats.

Book Edited

  • Ā Pradeep NS, Edison LK (Editors). 2022. Microbial Beta Glucanases – Molecular
    Structure, Functions and Applications. In Book Series: Interdisciplinary
    Biotechnological Advances. Springer Nature Singapore Pte Ltd., Pages 206. DOI
    https://doi.org/10.1007/978-981-19-6466-4, ISBNs 978-981-196465-7 (Hard cover),
    978-981-196466-4 (eBook).

Book chapters

  • Edison LK, Pradeep NS. Isolation of beta-glucanase encoding genes from actinobacterial
    genus Streptomyces spp. and its overexpression in Escherichia coli heterologous system. In:
    Karthik L, ed. Protocols of Actinomycetes: Microbiology to Gene Editing. 1st ed. Boca Raton,
    FL: CRC Press; 2024:Chapter 11. doi:10.1201/9781003398400-11
  • Nair S, Sahay B, Arukha AP, Edison LK, Crews CD, Morris JG Jr, Kariyawasam S,
    Yamamoto JK. Interferon-γ/IL-2 ELISpot and mRNA Responses to the SARS-CoV2, Feline
    Coronavirus Serotypes 1 (FCoV1), and FCoV2 Receptor Binding Domains by the T Cells
    from COVID-19-Vaccinated Humans and FCoV1-Infected Cats. Methods Mol Biol.
    2024;2768:135-151. doi: 10.1007/978-1-0716-3690-9_9.
  • Ragitha VM, Edison LK. Safety issues, environmental impacts, and health effects of
    Biopolymers. In: Thomas S, Ar A, Jose Chirayil C, Thomas B, eds. Handbook of Biopolymers.
    Springer; 2022. doi:10.1007/978-981-16-6603-2_54-1.

Publication